Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.11
- Piotroski Score 2.00
- Grade Neutral
- Symbol (CALT)
- Company Calliditas Therapeutics AB (publ)
- Price $40.00
- Changes Percentage (-0.1%)
- Change -$0.04
- Day Low $40.00
- Day High $43.00
- Year High $43.00
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was incorporated in 2004 and is headquartered in Stockholm, Sweden.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/10/2024
- Fiscal Year End N/A
- Average Stock Price Target $39.50
- High Stock Price Target $40.00
- Low Stock Price Target $39.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.88
- Trailing P/E Ratio -21.01
- Forward P/E Ratio -21.01
- P/E Growth -21.01
- Net Income $-466,185,000
Income Statement
Quarterly
Annual
Latest News of CALT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Students Paid Thousands for a Caltech Boot Camp. Caltech Didn't Teach It.
Raymond Sewer enrolled in an online cloud computing program with Caltech, expecting a legitimate course. However, he found the program was outsourced to Simplilearn, lacking Caltech's involvement. Man...
By The New York Times | 1 month ago -
Caltrain completes rollout of all-electric fleet between San Jose, San Francisco
Caltrain launched fully electric service between San Francisco and San Jose, marking a milestone in a $2.4 billion project. The new eco-friendly and faster trains aim to enhance service, reduce emissi...
By CBS News | 1 month ago -
Caltrain rolls out all-electric fleet in San Francisco
California is transitioning to all-electric trains, celebrating Caltrain's move as a model for the future. The electrification project aims to revolutionize rail travel in the region, with faster and ...
By CBS News | 2 months ago
